Gianni Sava

Gianni Sava was born at Gemona del Friuli, Udine, Italy, on September 9th, 1952. He received the Diploma of Scientific Liceum, in 1971, Udine, Italy; and the degree in biological sciences, in 1975, University of Trieste, Italy. He is a Full Professor of pharmacology in the Faculty of Pharmacy, University of Trieste, since 2002. Since 1992, he is a Scientific Director of Callerio Foundation Onlus, since 2003, he is Head of the Department of Biomedical Sciences, and since 2006, he is the President of the Council of the Scientific Structures, University of Trieste. His scientific expertises are in the in vivo and in vitro pharmacology of compounds active on metastases of solid tumours, metal-based drugs for cancer chemotherapy. He is a Coordinator of the Working Group on “Intracellular and Extracellular Targets for Antitumour and Toxicicity of Ruthenium Complexes”, COST D20, 2001–2006; and a Coordinator of the Working Group on “New Targets for Metal-based Drugs: Behyond DNA”, COST D39, since 2007. He has 230 full-lenght papers (95%) in international peer-reviewed journals; over 300 presentations (posters and oral) at conferences, and a member in the Editorial Board of In Vivo, Pathology and Oncology Research, and Editor-in-chief of Metal-Based Drugs.

Biography Updated on 1 November 2007

Scholarly Contributions [Data Provided by ]